Short Interest in 111, Inc. (NASDAQ:YI) Expands By 94.1%

111, Inc. (NASDAQ:YI) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 6,600 shares, an increase of 94.1% from the February 28th total of 3,400 shares. Based on an average daily volume of 40,600 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.1% of the shares of the company are short sold.

Institutional Trading of 111

A number of hedge funds have recently made changes to their positions in YI. JPMorgan Chase & Co. grew its holdings in 111 by 43,619.9% during the 4th quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company’s stock valued at $191,000 after buying an additional 305,339 shares during the last quarter. Napean Trading & Investment Co Singapore PTE Ltd acquired a new stake in 111 in the fourth quarter worth $245,000. Finally, FIL Ltd bought a new position in 111 during the 4th quarter worth approximately $450,000. 21.32% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of 111 in a research note on Saturday, March 22nd.

111 Stock Down 0.6 %

NASDAQ YI opened at $9.80 on Friday. 111 has a 12-month low of $4.15 and a 12-month high of $14.10. The firm has a market cap of $83.81 million, a price-to-earnings ratio of -2.45 and a beta of 0.46. The company has a 50-day simple moving average of $7.66 and a two-hundred day simple moving average of $7.41.

111 (NASDAQ:YI) last released its quarterly earnings results on Thursday, March 20th. The company reported ($0.04) EPS for the quarter. The business had revenue of $527.14 million during the quarter.

About 111

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.